Michelle Gallant

U.S. Marketing Director at Liquidia

Michelle Gallant has a diverse work experience in the field of marketing and pharmaceuticals. Michelle is currently working as the U.S. Marketing Director at Liquidia Corporation since January 2022. Before that, they worked as a Marketing Consultant on a self-employed basis from March 2021 to December 2021. Prior to that, they held the position of Senior Director, Global Marketing at PTC Therapeutics, Inc. from November 2019 to September 2020. Additionally, they worked as a Consultant at Amryt Pharma plc from July 2019 to November 2019. Michelle also has experience at Sanofi Genzyme as the U.S. Brand Lead for ELITEK Marketing from October 2018 to April 2019.

Before that, Michelle worked at Aegerion Pharmaceuticals starting from November 2013, where they held multiple roles including Global Brand Director, Director of International Marketing, Associate Director of International Marketing, and Senior International Product Manager.

Michelle'searlier experience includes working as an Associate Director of U.S. Marketing, Endocrinology at Genzyme from March 2013 to November 2013. Michelle also worked at Genzyme Corporation from September 2005 to March 2013, where they held positions such as Senior Product Manager, Product Manager, Associate Product Manager, and Sales and Events Coordinator.

Michelle started their career at Millennium Pharmaceuticals as an Administrative Associate from November 2003 to September 2005. Overall, Michelle Gallant has a solid background in marketing and a wealth of experience in the pharmaceutical industry.

Michelle Gallant has a Bachelor of Science degree in Mass Communication from Iona University, which they obtained from 1994 to 1998. In 2005, they attended Boston University to study Project Management. In 2008, they briefly attended UCLA Anderson School of Management to focus on Medical Marketing.

Links

Previous companies

PTC Therapeutics logo
Amryt Pharma logo
Sanofi logo

Org chart

Timeline

  • U.S. Marketing Director

    January, 2022 - present

View in org chart